Agenus Inc. (“Agenus”) (NASDAQ: AGEN), a leader in discovering and developing novel immunological agents to treat various cancers, today announced that Dr. Garo Armen, Chairman and CEO, and Robin Taylor, Chief Commercial Officer, will participate in a fireside chat and investor one-on-ones at the upcoming Goldman Sachs Global Healthcare Conference on June 10th – 13th in Miami Beach, Florida. The fireside chat will take place at 8:00 a.m. ET on June 12th.

A live webcast and replay of the fireside chat will be accessible on the company’s website at https://investor.agenusbio.com/events-and-presentations/.

About Agenus

Agenus is a leading immuno-oncology company targeting cancer and infectious diseases with a comprehensive pipeline of immunological agents. The company’s mission is to expand patient populations benefiting from cancer immunotherapy through combination approaches, using a broad repertoire of antibody therapeutics, adoptive cell therapies (through MiNK Therapeutics) and adjuvants (through SaponiQx). Agenus is headquartered in Lexington, MA. For more information, visit www.agenusbio.com or @agenus_bio. Information that may be important to investors will be routinely posted on our website and social media channels.

Investor 917-362-1370 investor@agenusbio.com

Media 612-839-6748 communications@agenusbio.com

Agenus (NASDAQ:AGEN)
과거 데이터 주식 차트
부터 1월(1) 2025 으로 2월(2) 2025 Agenus 차트를 더 보려면 여기를 클릭.
Agenus (NASDAQ:AGEN)
과거 데이터 주식 차트
부터 2월(2) 2024 으로 2월(2) 2025 Agenus 차트를 더 보려면 여기를 클릭.